Vanda Pharmaceuticals reported $8.64M in Operating Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Agios Pharmaceuticals AGIO:US $ -102.18M 13.03M
Arrowhead Research ARWR:US $ 41.55M 104.87M
AstraZeneca AZN:LN -292000000 1.38B
Bluebird Bio BLUE:US $ -135.67M 81.29M
Enanta Pharmaceuticals ENTA:US $ -33.85M 3.44M
Lexicon Pharmaceuticals LXRX:US -23380000 1.95M
Minerva Neurosciences NERV:US $ -7.99M 13.39M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Teva Pharmaceutical TEVA:IT 78M 545M